Sign in Register
Posted On: 22 September 2019 05:21 pm
Updated On: 22 September 2019 11:03 pm

MoPH tells pharmacies to withdraw all medications containing 'Ranitidine' immediately

nabeela
nabeela
Content Writer
Discuss here!
Start a discussion
Ranitidine

The Ministry of Public Health has asked pharmacies in Qatar to withdraw, suspend and stop trading all medication that contains Ranitidine in concentrated doses and in all of its pharmaceutical forms as a temporary precautionary measure. This precautionary measure is being taken while the Ministry of Health's laboratories and certified laboratories test medications containing Ranitidine.

Which medicines has MoPH asked pharmacies to withdraw

MoPH tells pharmacies to withdraw all medications containing 'Ranitidine' from pharmacies immediately
Image credit: MoPH

This precaution is being taken after the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) conducted tests on the medication and discovered that it contained a Nnitrosodimethylamine (NDMA) in low levels. Nnitrosodimethylamine (NDMA) may cause cancer it is present in big quantities.

The MoPH said its Department of Pharmacy and International Control is coordinating with international regulatory bodies to follow up on the latest developments.

The Ministry clarifies that it will issue the appropriate final decision as soon as the results of the final international or local tests on these drugs are issued.

In the meantime, patients who use these drugs should review and consult their doctor, and those who use them without a prescription should use other alternatives.

What is Ranitidine?

Ranitidine is a well-known and widely used antacid and antihistamine. It is used for the treatment of a number of gastrointestinal disorders and their prevention. NDMA is a likely human carcinogen found in cooked or cured meats such as bacon, and is a common industrial byproduct, according to Bloomberg.

Do you use Ranitdine, or any of its forms? What will you do now? Do let us know in our Comments section. Like and share the article - it keeps us going!